About Oncgnostics
Oncgnostics is a company based in Jena (Germany) founded in 2012.. Oncgnostics has raised $1.42 million across 5 funding rounds from investors including STIFT, Seedmatch and bm|t. The company has 12 employees as of December 31, 2020. Oncgnostics operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter Jena, Germany
- Employees 12 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$18.93 K (USD)-95as on Dec 31, 2020
-
Net Profit
$897.25 K (USD)20as on Dec 31, 2020
-
EBITDA
-
Total Equity Funding
$1.42 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
STIFT
& 5 more
-
Employee Count
12
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oncgnostics
Oncgnostics has successfully raised a total of $1.42M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Series B - Oncgnostics | Valuation |
investors |
|
| Jun, 2018 | Amount | Series A - Oncgnostics | Valuation |
investors |
|
| Jun, 2016 | Amount | Series A - Oncgnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Oncgnostics
Oncgnostics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include STIFT, Seedmatch and bm|t. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and private equity investments are managed by bm|t.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Oncgnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oncgnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncgnostics Comparisons
Competitors of Oncgnostics
Oncgnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncgnostics
Frequently Asked Questions about Oncgnostics
When was Oncgnostics founded?
Oncgnostics was founded in 2012.
Where is Oncgnostics located?
Oncgnostics is headquartered in Jena, Germany. It is registered at Jena, Thuringia, Germany.
Is Oncgnostics a funded company?
Oncgnostics is a funded company, having raised a total of $1.42M across 5 funding rounds to date. The company's 1st funding round was a Series A of $553.55K, raised on Apr 16, 2012.
How many employees does Oncgnostics have?
As of Dec 31, 2020, the latest employee count at Oncgnostics is 12.
What is the annual revenue of Oncgnostics?
Annual revenue of Oncgnostics is $18.93K as on Dec 31, 2020.
What does Oncgnostics do?
Oncgnostics was founded in 2012 in Jena, Germany, and operates in the biotechnology sector. Epigenetic biomarkers are developed for cancer detection and diagnosis. GynTect is offered to identify methylated DNA regions in precancerous and carcinoma cells through PCR-based technologies. Operations focus on advancing diagnostic tools for gynecological cancers, with research and development centered in Europe.
Who are the top competitors of Oncgnostics?
Oncgnostics's top competitors include Guardant Health, Foundation Medicine and Natera.
Who are Oncgnostics's investors?
Oncgnostics has 6 investors. Key investors include STIFT, Seedmatch, bm|t, Balmung Capital, and Sparkasse Jena-Saale-Holzland.